Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

Conditions:   Desmoplastic Small Round Cell Tumor;   Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Desmoplastic Small Round Cell Tumor;   Recurrent Malignant Peripheral Nerve Sheath Tumor;   Recurrent Malignant Solid Neoplasm;   Recurrent Neuroblastoma;   Recurr ent Rhabdomyosarcoma;   Refractory Desmoplastic Small Round Cell Tumor;   Refractory Malignant Peripheral Nerve Sheath Tumor;   Refractory Malignant Solid Neoplasm;   Refractory Neuroblastoma;   Refractory Rhabdomyosarcoma Interventions:   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Cyclosporine;   Drug: Etoposide;   Drug: Fludarabine Phosphate;   Biological: Lapine T-Lymphocyte Immune Globulin;   Drug: Melphalan;   Drug: Mycophenolate Mofetil;   Drug: Tacrolimus;   Drug: Thiotepa Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials